Addressing Challenges to Alternative Payment Models for New Alzheimer's Disease Therapies for US Commercial Payers. [PDF]
Pharmacoeconomics, 2022 Hlávka JP +3 more
europepmc +1 more source
Emerging trends in pharmaceutical payment models: Perspectives on the 2024 AMCP Foundation Survey. [PDF]
J Manag Care Spec PharmKenney JT, Gleason PP.
europepmc +1 more source
Payment models and the sustainability of community pharmacy practice: a qualitative interview study with community pharmacists. [PDF]
J Pharm Policy PractSchmidtke KA, Warholak T.
europepmc +1 more source
Use of alternative payment models for substance use disorder prevention in the United States: development of a conceptual framework. [PDF]
Subst Abuse Treat Prev PolicyRosenfeld E +10 more
europepmc +1 more source
Cost of Joint Replacement Using Bundled Payment Models
JAMA Internal Medicine, 2017 A. Navathe +6 more
semanticscholar +1 more source
Characterizing a heterogeneous chronic patient population for redesigning person-centred bundled payment models using risk-mitigating measures. [PDF]
Eur J Health EconBour SS, Goossens LMA, Mölken MPMHR.
europepmc +1 more source
A set of appropriate financing and payment models for personalised medicine for different types of health care systems in ...
openaire +1 more source
How Benchmark Changes Affect Participation in Accountable Care Organizations: Prospects for Voluntary Payment Models. [PDF]
Am J Health EconChen AJ, McWilliams JM.
europepmc +1 more source
Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews. [PDF]
Front PharmacolDesmet T +5 more
europepmc +1 more source